MJP Associates’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-2,857
Closed -$235K – 258
2025
Q3
$235K Buy
2,857
+99
+4% +$7.79K 0.03% 222
2025
Q2
$222K Sell
2,758
-362
-12% -$27.9K 0.03% 206
2025
Q1
$250K Buy
3,120
+101
+3% +$8.4K 0.05% 182
2024
Q4
$247K Buy
3,019
+40
+1% +$3.33K 0.04% 192
2024
Q3
$246K Sell
2,979
-175
-6% -$13.1K 0.05% 175
2024
Q2
$221K Sell
3,154
-74
-2% -$5.28K 0.05% 207
2024
Q1
$239K Buy
+3,228
New +$225K 0.05% 204
2023
Q1
– Sell
-2,968
Closed -$215K – 148
2022
Q4
$215K Buy
+2,968
New +$213K 0.06% 122
2022
Q3
– Sell
-3,212
Closed -$202K – 138
2022
Q2
$202K Sell
3,212
-12
-0.4% -$794 0.06% 131
2022
Q1
$227K Sell
3,224
-370
-10% -$25K 0.06% 141
2021
Q4
$227K Buy
3,594
+136
+4% +$8.54K 0.07% 143
2021
Q3
$213K Sell
3,458
-105
-3% -$6.32K 0.07% 132
2021
Q2
$213K Buy
3,563
+24
+0.7% +$1.52K 0.07% 129
2021
Q1
$215K Buy
+3,539
New +$195K 0.09% 120

Other funds holding MET

MJP Associates's MET Position: Q4 2025 in Review

MJP Associates sold out of MetLife (MET) in Q4 2025, closing a stake of 2,857 shares — an estimated $235K sold.

MJP Associates first reported a position in MET in Q1 2021 and held it in 14 quarters. The position peaked at $250K in Q1 2025. 1,447 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • MJP Associates reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
  • MJP Associates sold 2,857 MetLife shares in Q4 2025, an estimated $235K.
  • MJP Associates first reported a position in MetLife in Q1 2021 and held it in 14 quarters.
  • MJP Associates's MetLife position peaked at $250K in Q1 2025.
  • 1,447 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on MJP Associates's 13F filing for Q4 2025, filed 6 Feb 2026.